{"id":387535,"date":"2020-11-24T08:03:30","date_gmt":"2020-11-24T13:03:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=387535"},"modified":"2020-11-24T08:03:30","modified_gmt":"2020-11-24T13:03:30","slug":"baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/","title":{"rendered":"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind."},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind.<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>Construction currently underway; expected to be completed in 2021<\/i><\/li>\n<li><i>Expanded facilities expected to support approximately 100 new jobs locally<\/i><\/li>\n<\/ul>\n<p>DEERFIELD, Ill.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nBaxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced a $50 million expansion of its sterile fill\/finish manufacturing facilities located in Bloomington, Ind. These facilities are operated by Baxter\u2019s BioPharma Solutions business, a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals. The expansion is being funded by a combination of Baxter and client investment. Additional details of the agreement were not disclosed.\n<\/p>\n<p>\nThe planned expansion of existing facility infrastructure includes construction of a new 25,000 square foot warehouse; a new filling line for flexible plastic containers; a high-speed automated syringe fill line capable of filling up to 600 units per minute and a new high-speed automated visual inspection line. Construction is currently underway and is expected to be completed in 2021. Contract product manufacturing in the expanded facilities is expected to begin in 2022. The new facilities will support programs that are expected to add approximately 100 new jobs at the site, in addition to jobs created due to construction.\n<\/p>\n<p>\n\u201cWe pride ourselves on being a contract manufacturing partner with the specialized expertise, proven experience, and facilities to help our clients successfully achieve their sterile manufacturing objectives,\u201d said Marie Keeley, vice president, BioPharma Solutions. \u201cOur Bloomington facility is already a global leader in sterile contract manufacturing, and this expansion will add capacity and state-of-the-art technology that will better enable us to meet the diverse needs of our clients and the patients they serve.\u201d\n<\/p>\n<p>\nThe Bloomington site currently manufactures life-saving products for approximately 25 pharmaceutical and biotechnology companies. The site has capabilities and expertise in parenteral delivery systems and clinical and commercial vaccine manufacturing, including preventive and seasonal vaccines for global markets. In addition, Bloomington offers a range of production and commercialization services, including clinical development, formulation, packaging and commercial launch capabilities. The site is also home to the Lyophilization Center of Excellence, an industry-leading resource center focused on the development of high-quality freeze drying.\n<\/p>\n<p><b>About Baxter BioPharma Solutions<\/b><\/p>\n<p>\nTogether with its sister contract manufacturing facility in Halle (Westfalen) Germany, Baxter BioPharma Solutions offers services for prefilled syringes, liquid and lyophilized vials and cartridge filling as well as specialized capabilities for cytotoxics and biologics manufacturing. For more information on BioPharma Solutions, visit: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.baxterbiopharmasolutions.com%2F&amp;esheet=52335509&amp;newsitemid=20201124005593&amp;lan=en-US&amp;anchor=www.BaxterBioPharmaSolutions.com&amp;index=1&amp;md5=a376d285dea4e0aae47d8e5e25db71c0\">www.BaxterBioPharmaSolutions.com<\/a>.\n<\/p>\n<p><b>About Baxter<\/b><\/p>\n<p>\nEvery day, millions of patients and caregivers rely on Baxter\u2019s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we\u2019ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter\u2019s employees worldwide are now building upon the company\u2019s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.baxter.com%2F&amp;esheet=52335509&amp;newsitemid=20201124005593&amp;lan=en-US&amp;anchor=www.baxter.com&amp;index=2&amp;md5=95b86f1ae6c7de53f38d76fa74a537f5\">www.baxter.com<\/a> and follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fbaxter_intl%3Fref_src%3Dtwsrc%255Egoogle%257Ctwcamp%255Eserp%257Ctwgr%255Eauthor&amp;esheet=52335509&amp;newsitemid=20201124005593&amp;lan=en-US&amp;anchor=Twitter&amp;index=3&amp;md5=2de57b74e571fa40f662200ca2a2baa5\">Twitter<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbaxter-healthcare%2F&amp;esheet=52335509&amp;newsitemid=20201124005593&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=c0f6d8b96d9a759c9f0e85c5bf9b4361\">LinkedIn<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FBaxterInternationalInc%2F&amp;esheet=52335509&amp;newsitemid=20201124005593&amp;lan=en-US&amp;anchor=Facebook&amp;index=5&amp;md5=d01fcb6fb438b33e089894f4083d2f71\">Facebook<\/a>.\n<\/p>\n<p><i>This release includes forward-looking statements concerning Baxter BioPharma Solutions, including the proposed investment in the expansion of its facilities. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: the company\u2019s ability to finance and develop new products or enhancements; satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter&#8217;s most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter&#8217;s website. Baxter does not undertake to update its forward-looking statements.<\/i><\/p>\n<p>\nBaxter is a registered trademark and BioPharma Solutions is a trademark of Baxter International Inc.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201124005593r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201124005593\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201124005593\/en\/<\/a><\/span><\/p>\n<p><b>Media Contact<br \/>\n<\/b><br \/>Eric Tatro, (224) 948-5353<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:media@baxter.com\">media@baxter.com<\/a><\/p>\n<p><b>Investor Contact<br \/>\n<\/b><br \/>Clare Trachtman, (224) 948-3020\n<\/p>\n<p><b>KEYWORDS:<\/b> Indiana Illinois United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Other Manufacturing Medical Supplies Health Medical Devices Logistics\/Supply Chain Management Transport Manufacturing<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201124005593\/en\/154729\/3\/baxter_blue.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind. Construction currently underway; expected to be completed in 2021 Expanded facilities expected to support approximately 100 new jobs locally DEERFIELD, Ill.&#8211;(BUSINESS WIRE)&#8211; Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced a $50 million expansion of its sterile fill\/finish manufacturing facilities located in Bloomington, Ind. These facilities are operated by Baxter\u2019s BioPharma Solutions business, a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals. The expansion is being funded by a combination of Baxter and client investment. Additional details of the agreement were not disclosed. The planned expansion of existing facility infrastructure includes construction of a new &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-387535","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind. Construction currently underway; expected to be completed in 2021 Expanded facilities expected to support approximately 100 new jobs locally DEERFIELD, Ill.&#8211;(BUSINESS WIRE)&#8211; Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced a $50 million expansion of its sterile fill\/finish manufacturing facilities located in Bloomington, Ind. These facilities are operated by Baxter\u2019s BioPharma Solutions business, a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals. The expansion is being funded by a combination of Baxter and client investment. Additional details of the agreement were not disclosed. The planned expansion of existing facility infrastructure includes construction of a new &hellip; Continue reading &quot;Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-24T13:03:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201124005593r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\\\/Finish Manufacturing Site in Bloomington, Ind.\",\"datePublished\":\"2020-11-24T13:03:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/\"},\"wordCount\":709,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201124005593r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/\",\"name\":\"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\\\/Finish Manufacturing Site in Bloomington, Ind. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201124005593r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-11-24T13:03:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201124005593r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201124005593r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\\\/Finish Manufacturing Site in Bloomington, Ind.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/","og_locale":"en_US","og_type":"article","og_title":"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind. - Market Newsdesk","og_description":"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind. Construction currently underway; expected to be completed in 2021 Expanded facilities expected to support approximately 100 new jobs locally DEERFIELD, Ill.&#8211;(BUSINESS WIRE)&#8211; Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced a $50 million expansion of its sterile fill\/finish manufacturing facilities located in Bloomington, Ind. These facilities are operated by Baxter\u2019s BioPharma Solutions business, a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals. The expansion is being funded by a combination of Baxter and client investment. Additional details of the agreement were not disclosed. The planned expansion of existing facility infrastructure includes construction of a new &hellip; Continue reading \"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-24T13:03:30+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201124005593r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind.","datePublished":"2020-11-24T13:03:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/"},"wordCount":709,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201124005593r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/","name":"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201124005593r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-11-24T13:03:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201124005593r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201124005593r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/baxter-biopharma-solutions-announces-50-million-investment-to-expand-sterile-fill-finish-manufacturing-site-in-bloomington-ind\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill\/Finish Manufacturing Site in Bloomington, Ind."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=387535"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387535\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=387535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=387535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=387535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}